Heron Therapeutics (NASDAQ: HRTX) revenue
Heron Therapeutics reported revenue of $154.9m for fiscal 2025, 7.4% more than in fiscal 2024 ($144.3m). Since fiscal 2016 its revenue has grown by 12,011.3%, an average growth of 70.4% a year.
Heron Therapeutics has grown its revenue for 4 years in a row, and fiscal 2025 is the highest of its 10 fiscal years on record. The biggest drop was in fiscal 2020, −39.3%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $154.9m | +7.4% | −$2.5m | −1.6% |
| 2024 | $144.3m | +13.6% | −$11.5m | −8.0% |
| 2023 | $127.0m | +18.0% | −$110.6m | −87.1% |
| 2022 | $107.7m | +24.7% | −$174.7m | −162.2% |
| 2021 | $86.3m | −2.6% | −$217.8m | −252.3% |
| 2020 | $88.6m | −39.3% | −$228.2m | −257.4% |
| 2019 | $146.0m | +88.4% | −$210.7m | −144.3% |
| 2018 | $77.5m | +151.8% | −$183.9m | −237.4% |
| 2017 | $30.8m | +2,305.6% | −$194.6m | −632.4% |
| 2016 | $1.3m | — | −$170.9m | −13,363.2% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Heron Therapeutics revenue compared with its sector
By revenue for its latest fiscal year, Heron Therapeutics ranks 261st of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Heron Therapeutics, 7.4%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 259th | Pacific Biosciences of California | $160.0m | 3.9% |
| 260th | Liquidia | $158.3m | 1,031.2% |
| 261st | Heron Therapeutics | $154.9m | 7.4% |
| 262nd | AirSculpt Technologies | $151.8m | −15.8% |
| 263rd | MacroGenics | $149.5m | −0.3% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Heron Therapeutics
- How much revenue did Heron Therapeutics make in fiscal 2025?
- Heron Therapeutics reported revenue of $154.9m for fiscal 2025, compared with $144.3m in fiscal 2024.
- How much has the revenue of Heron Therapeutics grown?
- Between fiscal 2016 and fiscal 2025 it went from $1.3m to $154.9m: 12,011.3% more, an average growth of 70.4% a year.
- What was the best year for revenue at Heron Therapeutics?
- Of its last 10 fiscal years, fiscal 2025, with $154.9m.
- Where does Heron Therapeutics rank in its sector by revenue?
- It ranks 261st of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Heron Therapeutics come from?
- From the annual report (Form 10-K) that Heron Therapeutics files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Heron Therapeutics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Heron Therapeutics: the Heron Therapeutics page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.